Depo-Provera brain tumor

Short answer: Depo-Provera (medroxyprogesterone acetate) has been linked to an elevated risk of intracranial meningioma — a type of brain tumor. Over 12,000 lawsuits have been filed against Pfizer as of 2026, consolidated into a federal MDL in the Northern District of Illinois. Women who used Depo-Provera for one year or more and later developed [...]

Breaking Depo-Provera lawsuit update: Pfizer files Daubert motion in the meningioma MDL ahead of June 24–26 causation hearings. 3,790 plaintiffs, settlement estimates $100K–$1.5M, who qualifies in 2026. Call 1 (855) 664-8713 for a free case review.

Get the latest Depo-Provera lawsuit update: 1,775+ MDL cases, meningioma risks, eligibility, settlements & how to join now.

🗓 Last Updated: May 2026 ✅ Reviewed by: TortAdvisor Editorial Team 📚 Sources: FDA, Federal Court, BMJ, PubMed ⚖️ Topic: Depo-Provera MDL No. 3140 Depo-Provera Settlement Amounts: 2026 Compensation Estimates If you developed a meningioma after using Depo-Provera or another medroxyprogesterone acetate injection, you may be researching potential settlement amounts. This guide explains estimated Depo-Provera [...]